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Case scenario
A distressed mother attends the clinic with her three year 
old daughter, who developed an itchy rash. The rash is reddish 
and affects her face and wrists. The child is restless and has 
been scratching all night. On close inspection atopic eczema is 
diagnosed. How would this case be managed and what issues 
may arise?
Introduction
Atopic eczema is a chronic, relapsing skin disorder 
characterized by a pruritic, erythematous and poorly demarcated 
skin eruption. It is a common condition in general practice. 
Seventy-five percent  of cases begin in the first 6 months of life 
and 80 to 90% occur before the age of 5 years.  The onset may 
occasionally be delayed until adult life. Sixty to 70% of affected 
children will be symptom free by their early teens although 
subsequent relapses are possible. At least 1 in 10 school children 
in Europe is affected.1   
The genetic basis of atopic eczema has not yet been fully 
understood. Probably inheritance requires genes that predispose 
to the state of atopy itself and others which determine whether it 
is eczema, asthma or hay fever. A genetic abnormality is possibly 
related to chromosomal region 11q13.2  Inheritance is thought 
to be either polygenic or autosomal dominant with variable 
penetrance, and probably through maternal transmission.3 
Environmental allergens have a role in atopic eczema. The 
hygiene hypothesis is based on the belief that the chance of 
developing atopic eczema is inversely related to exposure to 
environmental allergens. It has been suggested that the early 
use of antibiotics and a reduced exposure to infections, may 
inhibit the normal maturation of the immune system. which 
can predispose to atopy.1,4 Climate affects the development of 
atopic eczema. A study showed that a change from a subarctic 
to a subtropical climate for 4 weeks significantly improved skin 
symptoms and quality of life of patients and their families even 
after 3 months from their return.5 Lifestyle also seems to be 
associated.  Stress increases the risk of atopic eczema; in fact 
divorce or separation of parents and severe disease of a family 
member influence the risk of developing atopic eczema.6  Other 
implicated triggering factors include contact irritants (soap, 
wool, perfumes, detergents), aeroallergens (house dust mites, 
moulds and pollen) and food (eggs and dairy products).7-9
Clinical features
The most common features of atopic eczema are itching and 
scratching. There is quite a variation in the appearance of lesions 
between individuals, and the characteristics and distribution 
vary with age (Table 1). Most cases follow a waxing and waning 
pattern and from time to time patients have acute flare-ups. In 
between flare-ups the skin may appear normal but generally 
there is a tendency for skin dryness throughout life. Acute 
lesions are intensely pruritic, erythematous papules, frequently 
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associated with extensive excoriations, erosions and exudates. 
A sub-acute state, characterized by erythema, excoriations and 
scaling, is also recognized. Chronic eczema leads to thickened 
plaques of skin and prominent skin markings.10,11
Atopic eczema also has a non-dermatological clinical 
scenario, since it greatly affects the quality of life of patients and 
their families.12 These disturbances range from minor problems 
to major handicaps. It is essential that the general practitioner 
recognizes these symptoms since the patients’ mental health and 
social and emotional functioning seem to be more affected than 
the physical functioning.13 Sleep disturbances are common. Over 
60% of parents participating in a study reported that eczema 
affected how well they or their child slept. This was directly 
associated with the severity of the eczema.14 These disturbances 
can lead to delayed growth and development due to the fact that 
growth hormone levels rise during stages 3 and 4 of sleep, which 
may not be reached if sleep is recurrently disturbed.  Other 
sources of anxiety to both the child and the parents include 
school absences and bullying due to the dermatological features. 
These may lead to under performance of the child which would 
generate further anxiety. The emotional impact can become even 
more significant in the preteen and teen years. This spectrum of 
symptoms should be considered when offering treatment.  
Diagnosing atopic eczema
Diagnosis is based on assessment and clinical findings. Table 
2 illustrates the Williams Criteria for diagnosing atopic eczema.10 
Diagnosis is based on identifying one major criterion and three 
or more minor criteria.  Lab tests which could aid diagnosis 
especially in difficult cases include increased serum levels of 
IgE and peripheral blood eosinophilia. Skin prick tests are 
positive for most common allergens. Occasionally a skin biopsy 
is required. This reveals a state of chronic inflammation, which 
involves mast cells, lymphocytes, and eosinophils.15
Treatment
Managing atopic eczema requires a holistic approach. 
Explanation, reassurance and encouragement to both the 
patients and the parents are crucial. The pathology and course 
of the disease should be explained, avoiding scientific jargon 
which might confuse the patients.  It is important to explain 
that eczema is not contagious and that there is no need to isolate 
the child from other peers or siblings. Parents should also know 
what clinical features to look for which would need prompt 
referral to the doctor, including fever, erythema and warmth 
around the affected areas, and formation of pus-filled blisters. 
The concept of allergen and trigger factors avoidance should 
be explained.  Significant improvement can be obtained by 
simple measures such as wearing cotton underclothes instead 
of wool, keeping nails short, avoiding extremes of temperature 
and avoiding direct contact with detergents and other irritant 
chemicals. Household pets especially cats and dogs should be 
discouraged.11,16 Patients also benefit from reducing exposure 
to dust mites. Mattress, pillow and duvet covers and washing 
bedding at 55oC are effective methods of reducing exposure.17 
The role of diet in atopic eczema is conflicting. It is believed 
that food allergy is a trigger in 10% of cases. A milk free diet is 
however recommended. Breast feeding is also advised but there 
is little evidence that it modifies or prevents eczema.15  
 Follow up visits are of utmost importance to monitor 
the progress of the disease and to discuss any worries and 
difficulties encountered. Since eczema is associated with a 
psychological burden, the family doctor should also be on the 
look out for symptoms of anxiety and depression in both the 
children and their parents and offer the necessary treatment. 
Another important aspect in follow up is keeping a growth chart 
for children with chronic severe eczema, to detect any growth 
delays as early as possible. 
Table 1: Age related distribution of atopic eczema
Age group Distribution Pattern
Infant Face/scalp  Itchy/erythematous papules
 Non specific distribution elsewhere Vesicular/weeping lesions
  Occasionally hypo pigmentation
  Small scratch marks
Older child  Elbow/knee flexures Leathery, dry and excoriated
 Wrists/ankles Scratching may alter pattern
 Tends to be symmetrical
Mid-teens Limb flexures Remains clear or
 Hands Localized hand eczema or
  Generalized low grade eczema
Adults as in childhood  Tendency towards lichenification
 +/- trunk/face/hands More widespread but low grade
  White demographism striking 
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Medical treatment
Medical treatment focuses on adequate skin hydration, 
reducing inflammation and treating secondary infections. 
Patients and parents of younger patients should be made 
aware of the wide array of products available. The family doctor 
should discuss the expectations and concerns associated with 
the treatment offered.  
Emollients
The most fundamental step in fighting atopic eczema is 
re-hydration. The principle mode of action of emollients is 
improving the depleted lipid barrier of the skin thus reducing 
skin water loss. This reduces dryness and pruritus and increases 
the skin resistance to irritants. If used regularly, emollients 
reduce eczema flare ups and the need of topical steroids.18
Emollients are available as lotions, creams and ointments. 
The lipid content is lowest in lotions and highest in ointments. 
The higher the lipid content, the greasier and stickier the 
emollient feels. Choice of emollient should be based on 
individual preference, body site and level of skin dryness (Table 
3).18 Initially the emollient should be applied generously 3 times 
a day, preferably after bath or showering. Frequency might be 
increased to every hour if skin is very dry.
Topical steroids 
Topical steroids have been used to control atopic eczema for 
over 40 years. They are available in different potencies (Table 
4). The weakest steroid that controls the eczema should be used. 
Patients should be reviewed regularly and checked for local and 
systemic side effects. Elderly people and infants tend to have 
thinner skin, therefore weaker preparations should be used.  The 
National Institute for Clinical Excellence recommends using 
a once daily application of topical steroids. This has a lower 
risk of adverse effects, greater convenience for the patient and 
lower costs.19 
The use of ‘finger tip units’ (FTUs) is recommended. One 
FTU weighs 500mg and is roughly equivalent to the amount 
of cream or ointment that can be squeezed from a tube with a 
standard (5mm) nozzle onto an adult index finger from the finger 
tip to the first crease. One FTU is sufficient to treat a skin area 
about twice that of the flat of the hand with the fingers together. 
The FTUs required depend on the area to be treated and the age 
of the patient (Table 5).20
How should emollients 
be applied with topical steroids?
Inflamed skin should be treated with corticosteroids, whilst 
the rest of the skin should be treated with emollient. The two 
products should not be mixed since this would dilute the effect 
of the corticosteroid. A 30 minutes gap is recommended before 
applying the emollient to the inflamed skin previously treated 
with corticosteroids.18 
Antibiotics
If there is clinical evidence of a bacterial infection, 
flucloxacillin (or erythromycin if allergic) is the preferred oral 
antibiotic.  Microbiological investigations are recommended if 
there is no response to the antibiotic but practicality in general 
practice is debatable. There is no evidence that topical antibiotic 
and corticosteroid preparations are superior to topical steroids 
alone. Topical antibiotics should be avoided or reserved for 
single small lesions only. Also, there is no evidence that bath oils 
containing antimicrobials are more effective and their routine 
use is not recommended.21
Table 2: Williams Criteria 10
Major Criteria
1) Patient must have an itchy condition or parental 
report of scratching/rubbing in a child
Plus 3 or more of the following
1) History of itchiness in skin creases such as folds of the 
elbows, behind knees, front of ankles or around neck 
(or cheeks if <4years)
2) Personal history of asthma, or hay fever or other 
atopic disease in a first-degree relative in patients 
younger than 4 years
3) General dry skin in the last year
4) Visible flexural eczema (or eczema effecting the cheeks 
or forehead and outer limbs in children younger than 
4 years old)
5) Onset in first 2 years of life (not used if child is <4)
Table 3: Skin type and recommended product18
Skin Type   Product
Hairy skin                                  lotion
Weeping eczema                      cream
Mildly dry skin                          cream or lotion 
Moderately to severe dry skin ointment or cream
Table 4: Examples of topical corticosteroids 
of different potency
Potency Example
Weak 1% Hydrocortisone
Moderate Clobetasone butyrate (Eumovate®)
Strong Bethamethasone 17- valerate  (Betnovate®)
 Hydrocortisone butyrate (Locoid® )
Very strong Clobetasol propionate (Dermovate®)
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Calcineurin inhibitors 
– pimecrolimus and tacrolimus
Pimecrolimus and Tacrolimus are topical steroid-free 
medications with immune modulating and anti-inflammatory 
properties. They act by down-regulating the mediator release 
of cytokine expression of various cells which contribute to the 
inflammation. The National Institute for Clinical Excellence 
has issued guidelines in August 2004, regarding their use. 
Calcineurin inhibitors are recommended as an option in 
adults and children two years and older that have not been 
controlled by topical corticosteroids and when there is a serious 
risk of important adverse effects from further use of topical 
corticosteroids. 22
Preparations are costly, but seem to be safe, with occasional 
transient burning sensation being the most common side effect. 
This decreases with usage. Other less common side effects 
include headache, cough, fever, flu-like symptoms, muscle 
aches, folliculitis and acne. The risk of developing skin cancer 
and lymphoma when using these products appears to be very 
low but it is carefully being monitored.  Systemic absorption is 
low and skin atrophy is not a problem, hence these preparations 
are suitable for face, neck and flexures.23,24  
Antihistamines
Oral antihistamines are effective as systemic anti-pruritics, 
sedatives and mild anxiolytics. Histamine release is not the main 
cause of the itching, so the newer non-sedating antihistamines 
help less than might be expected.1
Other treatment options
Wet wrap dressing
During the last two decades wet wrap dressing has been 
advocated as a relatively safe and effective treatment option in 
children with severe and refractory atopic eczema, best used at 
night time. Large amounts of emollient and sometimes a mild 
topical steroid are applied under a damp layer of bandage. A 
second dry layer is then applied on top. As the bandage dries, 
the skin cools, reducing pruritus. This technique needs to be 
demonstrated to the patient’s parents. It is contraindicated 
in the presence of secondary infection. The use of wet wrap 
dressing with diluted topical corticosteroids for up to 14 days 
is a safe intervention treatment in children, with temporary 
systemic bioactivity of the corticosteroid as the only reported 
serious side effect. 25
Coal tar and ichthammol
Coal tar and ichthammol are used for chronic lichenified 
eczema. They may be applied as crude coal tar, tar-containing 
creams or in combination with zinc paste. This is not suitable 
for facial use and side effects include skin irritation, folliculitis 
and staining. 
Prebiotics
Orally administered prebiotics  e.g. Lactobacillus and 
Bifido bacterium species might help prevent and treat atopic 
disorders.26 This is based on the hypothesis that atopic 
individuals have alterations in their intestinal micro flora as 
compared to unaffected individuals. Restoring these imbalances 
would therefore decrease the symptoms. Prebiotics modulate 
the post-natal development of the immune system via the gut 
Table 5: FTUs related to age and area to be treated 20
   FTUs/Age     
  3-6 months  1-2 years     3-5 years 6-10 years         adults
Entire area              
Face and neck 1 1.5 1.5             2 2.5
Arm and hand 1 1.5 2 2.5 4
Leg and foot 1.5 2 3 4.5 8
Chest and abdomen  1 2 3 3.5 7
Back and buttocks 1.5 3 3.5 5 7
Table 6: Type of referral related to clinical scenario 34
Emergency referral  
• Infection with disseminated HSV (Eczema 
herpeticum)
Urgent referral       
 • Severe disease not responding to treatment in primary 
care
 • Bacterial infection unresponsive to oral antibiotics 
 +/- topical steroid
Referral as soon as possible 
• Severe social and psychological problems arising 
from atopic eczema (e.g. sleeplessness and school 
absenteeism )
• Treatment requiring excessive amounts of potent 
topical steroids
Routine referral
• Failure to control symptoms in primary care
• If patient or family might benefit from additional 
advice on application of treatment (e.g. bandaging 
techniques)
• Patch testing if contact dermatitis is suspected
• Dietary factors are suspected (Routine referral to a 
dietician) 
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flora. Such modulation could have consequences on reduction of 
allergies and infections later in life.27 The prebiotic Lactobacillus 
rhamnosus GG when taken by a woman during pregnancy and 
then either continued during breast feeding or given to the baby, 
may help prevent the occurrence of atopic eczema in children 
with a family history of atopy. 28,29
Experimental treatments
Experimental treatments include trials of gamma interferon 
and interleukin-2.30 These are inhibitors of TH2 cell function, 
which appear to be hyperactive in atopic eczema. Results when 
using these treatments are promising. Oral mycophenolate 
mofetil, an inhibitor of purine synthesis, has also been shown in 
two small studies to be an effective alternative treatment.31
Complications and associated conditions
Patients suffering from atopic eczema have an increased 
propensity to develop dermatological infections. This is 
secondary to decreased immunity and reduced barrier 
function of the skin. Ninety percent of atopic eczema patches 
are colonized by Staphylococcus areus. It is being evaluated 
whether this is a cause rather than an effect of atopic eczema. 
There is also evidence that Malasezzia species are a cause 
of eczema with head and neck distribution. Patients are also 
prone to viral infections, including Molluscum contagiosum, 
warts and most dangerously widespread herpes simplex 
(eczema herpeticum). Viral infections are not as yet perceived 
as aetiological factors.32
There are various skin changes associated with atopic 
eczema. About 20% of patients develop icthyosis vulgaris with 
associated keratosis piliaris and hyper-linear palms.10 Keratosis 
piliaris produces a stippled skin appearance on thighs, legs, 
buttocks and trunks. Hyperlinear palms consist of increased 
number of fine lines and accentuated markings on the palms. 
Lichenification of the wrists, ankles, and popliteal fossa is 
characteristic of chronic eczema. This is observed as thickened, 
leather, hyper-pigmented skin.10
Atopic cataracts can occur in patients with very severe atopic 
eczema. These occur much earlier in life than senile cataracts. 
They are typically bilateral and central. Incidence appears to be 
unrelated to the use of topical steroids.10
Atopic eczema is also associated with other atopic conditions. 
Asthma or hay fever is found in about 50% of children with peak 
onset at 2 and 8 years respectively.33 
Referral criteria
A number of patients may need specialist care. The National 
Institute for Clinical Excellence has issued guidelines when this 
should occur (Table 6).34
Prognosis
Good prognostic factors include early age of onset and 
involvement of flexural surfaces. It is believed that more adults 
will be suffering from atopic eczema in the future, considering 
that the prevalence amongst children has increased and the 
fact that atopic eczema in most adults continues for many 
years.35,36
Conclusion
The clinical scenario illustrates a typical presentation of 
atopic eczema. The family doctor dealing with this case should 
start by explaining to the mother what atopic eczema is. Other 
important points to be mentioned during this first encounter 
include the concept of triggering factors, and what treatments 
are available. The child would benefit from a mild topical steroid 
applied daily in conjunction with an emollient cream, applied 
three times daily preferably after a bath or shower. A sedating 
anti-histamine administered before bed time is also indicated 
to help the child sleep better at night. A follow-up appointment 
should be organized after one week of treatment to assess the 
clinical improvement and act accordingly.  The mother should 
also be advised to consult the doctor, should any difficulties 
arise.   
Atopic eczema is a common chronic dermatological condition 
which has a considerable psychological burden. It affects not 
only the suffering child but also other family members. A holistic 
approach based on both medical and non-medical treatment 
should be offered by the caring family practitioner to improve the 
quality of life and make atopic eczema a bearable condition.     
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